$279.00

Ultra-advanced combination of triple-agonist Retatrutide with amylin analog Cagrilintide. Targets four metabolic receptor pathways simultaneously — GIP, GLP-1, glucagon, and amylin.

  • Phorm Labs

Description

Research Areas

  • Quad-pathway metabolic receptor research
  • Maximum appetite suppression signaling
  • Advanced obesity and metabolic syndrome models

Additional information

Weight .20 lbs
Dimensions 7 × 4 × 3 in
Please Select

10 mg

Reviews

There are no reviews yet.

Be the first to review “Lipo3(reta) 5mg + Cagrilintide 5mg”

Your email address will not be published. Required fields are marked *